Projects funded by the NCN

A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

Call: SONATA 20 , Panel: NZ7

Principal investigator: dr Joanna Dagmara Fedorowicz

Gdański Uniwersytet Medyczny

Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

Call: OPUS 28 , Panel: ST8

Principal investigator: dr hab. Bożena Anna Tyliszczak

Politechnika Krakowska im. Tadeusza Kościuszki

Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

Call: SONATA 18 , Panel: NZ7

Principal investigator: dr Urszula Helena Piotrowska

Warszawski Uniwersytet Medyczny

Interactions of statins with biological membranes - implications for drug delivery research.

Call: OPUS 16 , Panel: ST4

Principal investigator: prof. Renata Bilewicz

Uniwersytet Warszawski, Wydział Chemii

Nanostructure platform as an intelligent drug delivery system for molecular sygnals of cell death at glioblastoma cancer...

Call: SONATA 12 , Panel: NZ7

Principal investigator: dr Marta Kutwin

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Nauk o Zwierzętach

Genetic determinants of psychoactive substances addiction: research on the endophenotype associated with a lack of the r...

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Anna Maria Grzywacz

Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarsko-Stomatologiczny

Applications of High Resolution Magic Angle Spinning Spectroscopy in research of selected anticancer drug embedded in me...

Call: PRELUDIUM 7 , Panel: ST5

Principal investigator: Ewa Agnieszka Skorupska

Centrum Badań Molekularnych i Makromolekularnych PAN

Research on the coordination of biopolymer biosynthesi in flax and its constituens

Call: MAESTRO 3 , Panel: NZ1

Principal investigator: prof. Jan Szopa-Skórkowski

Uniwersytet Wrocławski, Wydział Biotechnologii

Novel, chemometrically assisted, metabolic based research strategy in anticancer drug development on the example of benz...

Call: PRELUDIUM 1 , Panel: NZ1

Principal investigator: Mariusz Marcin Belka

Gdański Uniwersytet Medyczny, Wydział Faramcautyczny z Oddziałem Medycyny Laboratoryjnej